We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Dopplar US Shows Embryonic Heart Failure

By HospiMedica staff writers
Posted on 30 Dec 2003
Dopplar ultrasound performed on pregnant women has identified embryonic congestive heart failure and subsequent risk of miscarriage. The results were presented at the annual meeting of the Radiological Society of North America (RSNA) in Chicago (IL, USA).

Endovaginal Doppler ultrasound imaging was performed on 1,530 pregnant women to evaluate heart function early in the first trimester by Jason C. Birnholz, M.D., president of Diagnostic Ultrasound Consultants (Oak Brook, IL, USA). Dr. Birnholz was able, for the first time, to identify congestive heart failure in embryos. The condition is characterized by increased free amniotic fluid and evidence of depressed myocardial contractility.

"Over 99% of pregnancies with an abnormal Doppler pattern do not continue,” said Dr. Birnholz. "The chances the pregnancy will continue are very high, about 95%, when Doppler ultrasound confirms normal embryonic heart function at six weeks.”

Dr. Birnholz found that congestive heart failure can be implicated in 40% of miscarriages. He noted that the Doppler technology provides higher sensitivity and higher specificity than conventional ultrasound and may eventually allow for early intervention. Prospective treatment, he speculated, might be as simple as providing supplemental oxygen to an expectant mother during the critical time of development.


Gold Member
12-Channel ECG
CM1200B
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Pediatric Cart
UXGLA-9PEDS
New
Shoulder Positioner
HE-JB2

Latest Patient Care News

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization